Allspring Global Investments Holdings LLC Has $5.91 Million Holdings in Docusign Inc. $DOCU

Allspring Global Investments Holdings LLC cut its position in Docusign Inc. (NASDAQ:DOCU) by 1.1% during the second quarter, Holdings Channel.com reports. The institutional investor owned 76,382 shares of the company’s stock after selling 885 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Docusign were worth $5,909,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DOCU. Wellington Management Group LLP boosted its position in Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock valued at $148,714,000 after buying an additional 1,440,269 shares in the last quarter. Duquesne Family Office LLC acquired a new position in shares of Docusign during the first quarter worth approximately $87,477,000. Pacer Advisors Inc. lifted its position in shares of Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company’s stock worth $95,017,000 after purchasing an additional 1,038,962 shares in the last quarter. Nuveen LLC acquired a new position in shares of Docusign during the first quarter worth approximately $50,459,000. Finally, Victory Capital Management Inc. lifted its position in shares of Docusign by 251.0% during the first quarter. Victory Capital Management Inc. now owns 734,588 shares of the company’s stock worth $59,795,000 after purchasing an additional 525,294 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Docusign Stock Up 1.2%

Shares of DOCU stock opened at $67.93 on Monday. The firm has a fifty day moving average of $75.02 and a 200-day moving average of $77.93. Docusign Inc. has a 12-month low of $66.35 and a 12-month high of $107.86. The company has a market capitalization of $13.66 billion, a price-to-earnings ratio of 51.08, a P/E/G ratio of 3.38 and a beta of 1.02.

Docusign (NASDAQ:DOCU) last released its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. The business had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities analysts expect that Docusign Inc. will post 1.17 EPS for the current year.

Insider Activity at Docusign

In other news, CFO Blake Jeffrey Grayson sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total transaction of $462,800.00. Following the completion of the sale, the chief financial officer owned 105,660 shares in the company, valued at approximately $7,522,992. This trade represents a 5.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider James P. Shaughnessy sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $71.19, for a total transaction of $533,925.00. Following the sale, the insider owned 55,442 shares of the company’s stock, valued at approximately $3,946,915.98. This represents a 11.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 102,533 shares of company stock worth $7,709,933 in the last quarter. 1.66% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of research reports. Citigroup upped their target price on shares of Docusign from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, September 4th. Wall Street Zen upgraded shares of Docusign from a “hold” rating to a “buy” rating in a research report on Saturday, September 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Docusign in a research report on Wednesday, October 8th. JPMorgan Chase & Co. upped their target price on shares of Docusign from $77.00 to $80.00 and gave the stock a “neutral” rating in a research report on Friday, September 5th. Finally, Piper Sandler boosted their price target on shares of Docusign from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $94.14.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.